Anti-CPT1B monoclonal antibody

Pre-made anti-CPT1B monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to CPT1B/CPT1B products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP0023-Ab-1/ GM-Tg-hg-IP0023-Ab-2Anti-Human CPT1B monoclonal antibodyHuman
GM-Tg-rg-IP0023-Ab-1/ GM-Tg-rg-IP0023-Ab-2Anti-Rat CPT1B monoclonal antibodyRat
GM-Tg-mg-IP0023-Ab-1/ GM-Tg-mg-IP0023-Ab-2Anti-Mouse CPT1B monoclonal antibodyMouse
GM-Tg-cynog-IP0023-Ab-1/ GM-Tg-cynog-IP0023-Ab-2Anti-Cynomolgus/ Rhesus macaque CPT1B monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP0023-Ab-1/ GM-Tg-felg-IP0023-Ab-2Anti-Feline CPT1B monoclonal antibodyFeline
GM-Tg-cang-IP0023-Ab-1/ GM-Tg-cang-IP0023-Ab-2Anti-Canine CPT1B monoclonal antibodyCanine
GM-Tg-bovg-IP0023-Ab-1/ GM-Tg-bovg-IP0023-Ab-2Anti-Bovine CPT1B monoclonal antibodyBovine
GM-Tg-equg-IP0023-Ab-1/ GM-Tg-equg-IP0023-Ab-2Anti-Equine CPT1B monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP0023-Ab-1/ GM-Tg-hg-IP0023-Ab-2; GM-Tg-rg-IP0023-Ab-1/ GM-Tg-rg-IP0023-Ab-2;
GM-Tg-mg-IP0023-Ab-1/ GM-Tg-mg-IP0023-Ab-2; GM-Tg-cynog-IP0023-Ab-1/ GM-Tg-cynog-IP0023-Ab-2;
GM-Tg-felg-IP0023-Ab-1/ GM-Tg-felg-IP0023-Ab-2; GM-Tg-cang-IP0023-Ab-1/ GM-Tg-cang-IP0023-Ab-2;
GM-Tg-bovg-IP0023-Ab-1/ GM-Tg-bovg-IP0023-Ab-2; GM-Tg-equg-IP0023-Ab-1/ GM-Tg-equg-IP0023-Ab-2
Products NameAnti-CPT1B monoclonal antibody
Formatmab
Target NameCPT1B
Protein Sub-locationIntrocelluar Protein
Category of antibodyTherapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-CPT1B monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP0023-Ag-1Recombinant multi-species CPT1B/ CPT1-M/ CPT1M protein
    ORF Viral VectorpGMLPm004731mouse Cpt1b Lentivirus plasmid
    ORF Viral VectorvGMLPm004731mouse Cpt1b Lentivirus particle


    Target information

    Target IDGM-IP0023
    Target NameCPT1B
    Gene ID1375,12895,25756,720697,481184,101083187,509459
    Gene Symbol and SynonymsCPT-IB,Cpt1,CPT1-M,CPT1B,CPT1M,CPTI,CPTI-M,M-CPT1,M-cpti,MCCPT1,MCPT1
    Uniprot AccessionQ92523,Q63704,Q58DK1
    Uniprot Entry NameCPT1B_HUMAN,CPT1B_RAT,CPT1B_BOVIN
    Protein Sub-locationIntrocelluar Protein
    CategoryTherapeutics Target
    DiseaseN/A
    Gene EnsemblENSG00000205560
    Target ClassificationN/A

    The target: CPT1B, gene name: CPT1B, also named as CPT1-M, CPT1M, CPTI, CPTI-M, M-CPT1, MCCPT1, MCPT1. The protein encoded by this gene, a member of the carnitine/choline acetyltransferase family, is the rate-controlling enzyme of the long-chain fatty acid beta-oxidation pathway in muscle mitochondria. This enzyme is required for the net transport of long-chain fatty acyl-CoAs from the cytoplasm into the mitochondria. Multiple transcript variants encoding different isoforms have been found for this gene, and read-through transcripts are expressed from the upstream locus that include exons from this gene. [provided by RefSeq, Jun 2009].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.